| Description |
1 online resource (1 PDF file (xiii, 69 pages)) : illustrations |
| Series |
Online access: NCBI NCBI Bookshelf
|
| Contents |
Introduction and highlights of the workshop -- Historical perspectives and context -- Scientific issues: clinically meaningful inclusion -- Recruitment and retention issues: patient, provider, institutional, and system barriers -- Potential best practices and policy options |
| Summary |
Even as the U.S. population becomes steadily more diverse, minorities and women remain underrepresented in clinical trials to develop new drugs and medical devices. Although progress in increasing minority participation in clinical trials has occurred, participation rates do not fully represent the overall population of minorities in the United States. This underrepresentation threatens the health of both these populations and the general population, since greater minority representation could reveal factors that affect health in all populations. Federal legislation has sought to increase the representation of minorities and women in clinical trials, but legislation by itself has not been sufficient to overcome the many barriers to greater participation. Only much broader changes will bring about the meaningful participation of all population groups in the clinical research needed to improve health. To examine the barriers to participation in clinical trials and ways of overcoming those barriers, the National Academies of Sciences, Engineering, and Medicine held a workshop in April 2015. This publication summarizes the presentations and discussions from the workshop |
| Bibliography |
Includes bibliographical references |
| Notes |
This activity was supported by the Aetna Foundation, Health Resources and Services Administration, Kaiser Permanente, The Kresge Foundation, Merck & Co., Inc., Methodist Health Ministries, and Office of Minority Health, U.S. Food and Drug Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project |
|
Online resource; title from PDF title page (viewed October 18, 2016) |
| Subject |
Clinical trials.
|
|
Discrimination in medical care.
|
|
Health services accessibility.
|
|
Ethnic groups.
|
|
Minorities.
|
|
Women.
|
|
Clinical Trials as Topic
|
|
Health Services Accessibility
|
|
Communication Barriers
|
|
Ethnicity
|
|
Healthcare Disparities
|
|
Minority Groups
|
|
Patient Selection
|
|
Women
|
|
ethnic groups.
|
|
minorities.
|
|
women (female humans)
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Women
|
|
Minorities
|
|
Ethnic groups
|
|
Clinical trials
|
|
Discrimination in medical care
|
|
Health services accessibility
|
| SUBJECT |
United States |
| Genre/Form |
proceedings (reports)
|
|
Conference papers and proceedings
|
|
Conference papers and proceedings.
|
|
Actes de congrès.
|
| Form |
Electronic book
|
| Author |
Olson, Steve, 1956- rapporteur
|
|
National Academies of Sciences, Engineering, and Medicine (U.S.). Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities.
|
|
National Academies of Sciences, Engineering, and Medicine (U.S.), issuing body.
|
|
Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials (Workshop) (2015 : Washington, D.C.)
|
| ISBN |
9780309443586 |
|
030944358X |
|
